Corteva announces name of new seed and genetics company
In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.
Read More
Riley patient is first in Indiana to receive gene therapy for blood condition
Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood cells to produce less hemoglobin than usual.
